Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mobile Health Interventions for Varenicline Adherence in HIV-positive Smokers
NCT04191278Phase 4Withdrawn
- Sponsor
- Duke University
- Start
- Nov 2021
- Primary completion
- Jul 2022
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Duke University. Primary endpoints: Average number of times per day participants initiate an interaction with mobile app, Average number of times per day participants respond to a prompt from mobile app and 3 more. Planned start Nov 2021; status: withdrawn.
Beyond the preview
Go deeper on NCT04191278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04191278.